ArticleEuropean journal of endocrinology2015

Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study.

Sebastian J C M M Neggers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.